数据来源与研究方法:

  • 对行业内相关的专家、厂商、渠道商、业务(销售)人员及客户进行访谈,获取最新的一手市场资料;
  • 艾凯咨询集团对长期监测采集的数据资料;
  • 行业协会、国家统计局、海关总署、国家发改委、工商总局等政府部门和官方机构的数据与资料;
  • 行业公开信息;
  • 行业企业及上、下游企业的季报、年报和其它公开信息;
  • 各类中英文期刊数据库、图书馆、科研院所、高等院校的文献资料;
  • 行业资深专家公开发表的观点;
  • 对行业的重要数据指标进行连续性对比,反映行业发展趋势;
  • 通过专家咨询、小组讨论、桌面研究等方法对核心数据和观点进行反复论证。

报告简介:

美国镇静药物及催眠药物市场报告

摘要

Calming And Sleeping Products in the US market report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data, allowing you to identify the sectors driving growth. It identifies the leading companies, the leading brands and offers strategic analysis of key factors influencing the market - be they new product developments, packaging innovations, economic/lifestyle influences, distribution or pricing issues. Forecasts illustrate how the market is set to change.

目录及图表

Table of contents

OTC HEALTHCARE IN THE US : MARKET INSIGHT

EXECUTIVE SUMMARY

OTC Industry Remains Innovative

Behind-the-counter Category Emerges

Johnson & Johnson Continues to Lead the Industry

Retailers Focus on Consumer Health

Economic Downturn Contributes to Industry Growth

KEY TRENDS AND DEVELOPMENTS

Consumers Self-medicate

Ageing Population Demands High Quality of Life

Leading Players Growth Through Consolidation

Behind-the-counter Category Emerges

Product Safety Concerns Erode Confidence in Manufacturers and FDA

MARKET INDICATORS

Table 1 Consumer Expenditure on Health Goods and Medical Services 2002-2007

Table 2 Life Expectancy at Birth 2002-2007

MARKET DATA

Table 3 Sales of OTC Healthcare by Sector: Value 2002-2007

Table 4 Sales of OTC Healthcare by Sector: % Value Growth 2002-2007

Table 5 OTC Healthcare Company Shares by Value 2003-2007

Table 6 OTC Healthcare Brand Shares by Value 2004-2007

Table 7 Penetration of Private Label by Sector 2003-2007

Table 8 Sales of OTC Healthcare by Distribution Format: % Analysis 2002-2007

Table 9 Sales of OTC Healthcare by Sector and Distribution Format: % Analysis 2007

Table 10 Forecast Sales of OTC Healthcare by Sector: Value 2007-2012

Table 11 Forecast Sales of OTC Healthcare by Sector: % Value Growth 2007-2012

APPENDIX

OTC Registration and Classification

Vitamins and Dietary Supplements Registration and Classification

Generics

Switches

Summary 1 OTC Healthcare Switches 2006-2008

DEFINITIONS

Summary 2 Research Sources

LOCAL COMPANY PROFILES - USA

ADAMS RESPIRATORY THERAPEUTICS INC - OTC HEALTHCARE - USA

STRATEGIC DIRECTION

KEY FACTS

Summary 3 Adams Respiratory Therapeutics Inc: Key Facts

Summary 4 Adams Respiratory Therapeutics Inc: Operational Indicators 2005-2007

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

Summary 5 Adams Respiratory Therapeutics Inc: Competitive Position 2007

CHATTEM INC - OTC HEALTHCARE - USA

STRATEGIC DIRECTION

KEY FACTS

Summary 6 Chattem Inc: Key Facts

Summary 7 Chattem Inc: Operational Indicators 2005-2007

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

Summary 8 Chattem Inc: Competitive Position 2007

GENERAL NUTRITION CENTERS INC - OTC HEALTHCARE - USA

STRATEGIC DIRECTION

KEY FACTS

Summary 9 General Nutrition Centers Inc: Key Facts

Summary 10 General Nutrition Centers Inc: Operational Indicators 2005-2007

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

Summary 11 General Nutrition Centers: Competitive Position 2007

MANNATECH INC - OTC HEALTHCARE - USA

STRATEGIC DIRECTION

KEY FACTS

Summary 12 Mannatech Inc: Key Facts

Summary 13 Mannatech Inc: Operational Indicators 2005-2007

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

Summary 14 Mannatech Inc: Competitive Position 2007

MCNEIL CONSUMER & SPECIALTY PHARMACEUTICALS - OTC HEALTHCARE - USA

STRATEGIC DIRECTION

KEY FACTS

Summary 15 McNeil Consumer & Specialty Pharmaceuticals: Key Facts

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

Summary 16 McNeil Consumer & Specialty Pharmaceuticals: Competitive Position 2007

MELALEUCA INC - OTC HEALTHCARE - USA

STRATEGIC DIRECTION

KEY FACTS

Summary 17 Mannatech Inc: Key Facts

Summary 18 Melaleuca Inc: Operational Indicators 2005-2007

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

Summary 19 Melaleuca Inc: Competitive Position 2007

NBTY INC - OTC HEALTHCARE - USA

STRATEGIC DIRECTION

KEY FACTS

Summary 20 NBTY Inc: Key Facts

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

Summary 21 NBTY: Competitive Position 2007

PROCTER & GAMBLE CO, THE - OTC HEALTHCARE - USA

STRATEGIC DIRECTION

KEY FACTS

Summary 22 Procter & Gamble Co, The: Key Facts

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

Summary 23 Procter & Gamble Co, The: Competitive Position 2007

WYETH CONSUMER HEALTHCARE INC - OTC HEALTHCARE - USA

STRATEGIC DIRECTION

KEY FACTS

Summary 24 Wyeth Consumer Healthcare Inc: Key Facts

Summary 25 Wyeth Consumer Healthcare Inc: Operational Indicators 2005-2007

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

Summary 26 Wyeth Consumer Healthcare Inc: Competitive Position 2007

CALMING AND SLEEPING PRODUCTS IN THE US

OVERVIEW

SECTOR DATA

Table 12 Sales of Calming and Sleeping Products: Value 2002-2007

Table 13 Sales of Calming and Sleeping Products: % Value Growth 2002-2007

Table 14 Calming and Sleeping Products Company Shares by Value 2003-2007

Table 15 Calming and Sleeping Products Brand Shares by Value 2004-2007

Table 16 Forecast Sales of Calming and Sleeping Products: Value 2007-2012

Table 17 Forecast Sales of Calming and Sleeping Products: % Value Growth 2007-2012


镇静药物催眠药物市场报